A carregar...
The Orphan Drug Act: An Appropriate Approval Pathway for Treatments of Rare Diseases?
The Orphan Drug Act provides financial incentives to pharmaceutical manufacturers to develop treatments for rare diseases affecting limited patient populations. Since passage of the Act in 1983, the U.S. Food and Drug Administration (FDA) has approved more than 600 orphan drug indications from great...
Na minha lista:
| Publicado no: | Hosp Pharm |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6751978/ https://ncbi.nlm.nih.gov/pubmed/31555002 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0018578719867665 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|